Kingsview Wealth Management Acquires New Stake in Amgen Inc.
Kingsview Wealth Management LLC has acquired a new stake in Amgen Inc. (NASDAQ:AMGN) shares, valued at approximately $6.78 million. The fund bought 18,729 shares of the medical research company's stock during the second quarter.
This is not an isolated case; several institutional investors have modified their holdings in Amgen. BlackRock Inc., for example, grew its position by 4.8% and now owns 49,362,016 shares of Amgen's stock, valued at $17,874,974,000.
Amgen has been performing well financially, with a recent quarterly earnings report exceeding analyst expectations. The company reported $6.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.62 by $0.67.